KAYLA FREEMAN: Open Payments
NPI 1932569258 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 7 payments from 7 companies in 2025. Trend: 2023 $28 · 2024 $164 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 1 | $110 |
| Janssen Biotech, Inc. | 1 | $27 |
| ARGENX US, INC. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Invivyd Inc | 1 | $15 |
Products named: BRIUMVI, VYVGART, Gamunex-C, EVENITY, PEMGARDA.
Industry payments across GA — which companies pay providers there.
